FDA approves Neuroreader software to help spot brain changes from Alzheimer’s, concussions

Danish medical device company Brainreader has announced FDA approval for its Neuroreader MR software designed to quickly detect changes in a patient’s brain volume brought on by neurodegenerative diseases or traumatic brain injuries.

The process works by uploading MR images to Neuroreader, which compares them against an FDA-approved database of healthy brain scans. In a matter of minutes, the software can measure 45 different brain structures and report back on changes as small as hundredths of a millimeter, according to a company press release.

Radiologists could use the software to accurately detect abnormalities resulting from Alzheimer’s disease, depression, concussion or a number of other conditions.

Neuroreader is a software-as-a-service product sold either through a subscription or pay-per-use.